Best Hospitals for Cystocele Repair (Anterior Colporrhaphy) in Chennai, India

A cystocele — also termed an anterior vaginal wall prolapse — occurs when the fascial and ligamentous support structures of the vesicovaginal septum attenuate or rupture, allowing the posterior wall of the urinary bladder to descend into, and sometimes protrude beyond, the vaginal introitus. The condition is staged using the internationally validated Pelvic Organ Prolapse Quantification (POP-Q) system, ranging from Stage I (asymptomatic, above the hymen) to Stage IV (complete eversion). Physiological consequences span a wide spectrum: obstructed voiding, incomplete bladder emptying with elevated post-void residual (PVR) volumes, recurrent urinary tract infections, stress or mixed urinary incontinence, dyspareunia, and — in advanced cases — bilateral hydroureteronephrosis from ureteral kinking. Risk factors include multiparity, instrumental delivery, connective tissue disorders (e.g., Ehlers-Danlos syndrome), chronic straining, obesity, and post-menopausal oestrogen deficiency.

Eligible CANDIDATES:

• Women with symptomatic cystocele POP-Q Stage II or higher causing voiding dysfunction, recurrent UTIs, pelvic pressure, or significant quality-of-life impairment
• Patients who have failed or declined conservative management (pelvic floor muscle training [Kegel exercises], pessary therapy, topical vaginal oestrogen)
• Women with concomitant stress urinary incontinence (SUI) confirmed on urodynamic testing, suitable for combined anterior colporrhaphy + mid-urethral sling
• Patients with post-void residual urine volume consistently >150 mL on bladder ultrasound
• Women with recurrent cystocele following prior native-tissue repair (candidates for mesh-augmented or robotic sacrocolpopexy)
• +1 more

Required Pre-operative DIAGNOSTICS:

NATIVE-TISSUE ANTERIOR COLPORRHAPHY (STANDARD APPROACH): The foundational procedure involves a midline anterior vaginal incision, sharp dissection of the vaginal epithelium from the underlying pubocervical fascia, central plication of the fascial layer using delayed-absorbable sutures (polyglactin 910 or polydioxanone), and excision of redundant vaginal skin followed by multilayer closure. Site-specific defect repair (paravaginal repair) addresses discrete lateral or apical fascial tears rather than central plication alone, and is associated with lower recurrence rates in appropriately selected patients. The Kelly stitch or modified Kelly plication specifically reinforces the urethrovesical junction and is employed when mild stress incontinence is present without a full sling procedure.

MESH-AUGMENTED ANTERIOR REPAIR: For recurrent prolapse or poor-quality native tissue, lightweight macroporous polypropylene mesh (e.g., Gynecare Prolift Anterior, Restorelle DirectFix Anterior) or biological grafts (porcine small intestinal submucosa, cadaveric dermal allograft) are sutured over the plicated fascia to provide durable scaffolding. Surgeons at GAF partner hospitals strictly adhere to the FDA and NICE guidance thresholds for mesh use — limiting synthetic mesh to specific recurrent or high-risk cases after thorough informed consent regarding mesh-specific complications (erosion, dyspareunia, chronic pain). Biological grafts are preferred in younger, sexually active patients.

CONCOMITANT MID-URETHRAL SLING (TVT / TOT): When urodynamic stress incontinence coexists, a retropubic tension-free vaginal tape (TVT, Gynecare) or transobturator tape (TOT, inside-out or outside-in) is placed at the mid-urethra in the same operative session. Urodynamic-proven occult stress incontinence — unmasked only after prolapse reduction — is addressed prophylactically with a sling to prevent de novo SUI post-repair.

ROBOTIC-ASSISTED SACROCOLPOPEXY (ADVANCED / MINIMALLY INVASIVE): For high-grade cystocele with concurrent apical (vault or uterine) prolapse, robotic-assisted laparoscopic sacrocolpopexy using the da Vinci Xi or Si system offers the highest anatomical durability (recurrence rates <10% at 5 years) with minimal blood loss (<50 mL), superior 3D optics for precise dissection of the vesicovaginal and rectovaginal spaces, and wristed instrumentation enabling secure mesh fixation to the anterior longitudinal ligament at the sacral promontory. This approach is available at JCI/NABH-accredited centres in Mumbai, Chennai, and Hyderabad, and at DHA-licensed hospitals in Dubai.

STEP 1 — REMOTE PRE-OPERATIVE EVALUATION (2–4 weeks before travel):

Upload existing medical records, imaging, and diagnostic reports to the GAF Healthcare patient portal. A urogynaecologist at the partner hospital reviews documents and issues a treatment plan, operative recommendation (native-tissue vs. mesh vs. robotic), and estimated costs within 48–72 hours. Any outstanding investigations (urodynamics, MRI) are scheduled at the destination hospital on arrival or, where possible, arranged locally before travel.

STEP 2 — ARRIVAL AND PRE-ADMISSION (Day 1–2):